{"id":"https://openalex.org/W1481098372","doi":"https://doi.org/10.1016/s0939-6411(02)00044-9","title":"Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2","display_name":"Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W1481098372","doi":"https://doi.org/10.1016/s0939-6411(02)00044-9","mag":"1481098372","pmid":"https://pubmed.ncbi.nlm.nih.gov/12084499"},"language":"en","primary_location":{"id":"doi:10.1016/s0939-6411(02)00044-9","doi":"https://doi.org/10.1016/s0939-6411(02)00044-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0939-6411(02)00044-9","pdf_url":null,"source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027923445","display_name":"Paul P. H. Le Brun","orcid":"https://orcid.org/0000-0002-8616-3809","observed_orcids":["https://orcid.org/0000-0002-8616-3809"]},"institutions":[{"id":"https://openalex.org/I4210087689","display_name":"Apotheek Haagse Ziekenhuizen","ror":"https://ror.org/003n39s44","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210087689"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"P.P.H Le Brun","raw_affiliation_strings":["Central Hospital Pharmacy, PO Box 43100, 2504 AC The Hague, The Netherlands. p.lebrun@ahz.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Hospital Pharmacy, PO Box 43100, 2504 AC The Hague, The Netherlands. p.lebrun@ahz.nl","institution_ids":["https://openalex.org/I4210087689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113791108","display_name":"Anne Haaije de Boer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A.H de Boer","raw_affiliation_strings":["Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands","Pharmaceutical Technology and Biopharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Pharmaceutical Technology and Biopharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028940838","display_name":"Gregor P.M. Mannes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.P.M Mannes","raw_affiliation_strings":["Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061964676","display_name":"D.M.I. de Fraiture","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.M.I de Fra\u0131\u0302ture","raw_affiliation_strings":["Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109102632","display_name":"Roland W. Brimicombe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R.W Brimicombe","raw_affiliation_strings":["Department of Medical Microbiology, Leyenburg Hospital, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Microbiology, Leyenburg Hospital, The Hague, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018163150","display_name":"Daan Johannes Touw","orcid":"https://orcid.org/0000-0002-1429-4789","observed_orcids":["https://orcid.org/0000-0002-1429-4789"]},"institutions":[{"id":"https://openalex.org/I4210087689","display_name":"Apotheek Haagse Ziekenhuizen","ror":"https://ror.org/003n39s44","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210087689"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D.J Touw","raw_affiliation_strings":["Central Hospital Pharmacy, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Hospital Pharmacy, The Hague, The Netherlands","institution_ids":["https://openalex.org/I4210087689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040060343","display_name":"Alexander A. T. M. M. Vinks","orcid":"https://orcid.org/0000-0003-4224-2967","observed_orcids":["https://orcid.org/0000-0003-4224-2967"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.A Vinks","raw_affiliation_strings":["Cincinnati Childrens's Hospital and Medical Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Childrens's Hospital and Medical Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008287871","display_name":"Henderik Willem Frijlink","orcid":"https://orcid.org/0000-0001-7901-8198","observed_orcids":["https://orcid.org/0000-0001-7901-8198"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H.W Frijlink","raw_affiliation_strings":["Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands","Pharmaceutical Technology and Biopharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Pharmaceutical Technology and Biopharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053308496","display_name":"Harry G.M. Heijerman","orcid":"https://orcid.org/0000-0002-8121-2843","observed_orcids":["https://orcid.org/0000-0002-8121-2843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.G.M Heijerman","raw_affiliation_strings":["Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Cystic Fibrosis Center, Leyenburg Hospital, The Hague, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5027923445"],"corresponding_institution_ids":["https://openalex.org/I4210087689"],"apc_list":{"value":4210,"currency":"USD","value_usd":4210},"apc_paid":null,"fwci":4.233,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.93863102,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"54","issue":"1","first_page":"25","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colistin","display_name":"colistin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/dry-powder-inhalation","display_name":"dry powder inhalation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/nebulization","display_name":"nebulization","score":0.7509999871253967},{"id":"https://openalex.org/keywords/colistin-sulfate","display_name":"colistin sulfate","score":0.8529999852180481},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.6079999804496765},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.984000027179718},{"id":"https://openalex.org/keywords/cough","display_name":"cough","score":0.9259999990463257},{"id":"https://openalex.org/keywords/inhaler-devices","display_name":"inhaler devices","score":0.5400000214576721},{"id":"https://openalex.org/keywords/antibiotic-delivery","display_name":"antibiotic delivery","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.923859715461731},{"id":"https://openalex.org/C2777419714","wikidata":"https://www.wikidata.org/wiki/Q1334805","display_name":"Dry-powder inhaler","level":4,"score":0.915492057800293},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.8902347087860107},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6419334411621094},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.6285824179649353},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.595766544342041},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42481905221939087},{"id":"https://openalex.org/C2779777708","wikidata":"https://www.wikidata.org/wiki/Q6033622","display_name":"Inhalation exposure","level":3,"score":0.411256343126297},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36729666590690613},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3611103892326355},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.3131346106529236},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24814966320991516},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.2381165325641632},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20863991975784302},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003091","descriptor_name":"Colistin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003091","descriptor_name":"Colistin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003091","descriptor_name":"Colistin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009330","descriptor_name":"Nebulizers and Vaporizers","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010361","descriptor_name":"Patients","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011208","descriptor_name":"Powders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012129","descriptor_name":"Respiratory Function Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012129","descriptor_name":"Respiratory Function Tests","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0939-6411(02)00044-9","doi":"https://doi.org/10.1016/s0939-6411(02)00044-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0939-6411(02)00044-9","pdf_url":null,"source":{"id":"https://openalex.org/S122302516","display_name":"European Journal of Pharmaceutics and Biopharmaceutics","issn_l":"0939-6411","issn":["0939-6411","1873-3441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics","raw_type":"journal-article"},{"id":"pmid:12084499","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12084499","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/ec036657-e23f-47fb-91d9-440b4d4715bf","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/ec036657-e23f-47fb-91d9-440b4d4715bf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Le Brun, P P H, de Boer, A H, Mannes, G P M, de Fra\u00eeture, D M I, Brimicombe, R W, Touw, D, Vinks, A A, Frijlink, H W & Heijerman, H G M 2002, 'Dry powder inhalation of antibiotics in cystic fibrosis therapy : Part 2. Inhalation of a novel colistin dry powder formulation: A feasibility study in healthy volunteers and patients', European Journal of Pharmaceutics and Biopharmaceutics, vol. 54, no. 1, PII S0939-6411(02)00044-9, pp. 25-32. https://doi.org/10.1016/S0939-6411(02)00044-9","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/ec036657-e23f-47fb-91d9-440b4d4715bf","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/ec036657-e23f-47fb-91d9-440b4d4715bf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Pharmaceutics and Biopharmaceutics, 54(1):PII S0939-6411(02)00044-9, 25 - 32. ELSEVIER SCIENCE BV","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1911569221","https://openalex.org/W1932524493","https://openalex.org/W1973414529","https://openalex.org/W1980112184","https://openalex.org/W1984655462","https://openalex.org/W1990346823","https://openalex.org/W2023174165","https://openalex.org/W2042222169","https://openalex.org/W2070131010","https://openalex.org/W2073087868","https://openalex.org/W2092126555","https://openalex.org/W2100739350","https://openalex.org/W2102645543","https://openalex.org/W2155069031","https://openalex.org/W2321958627","https://openalex.org/W2412583831","https://openalex.org/W2502670554"],"related_works":["https://openalex.org/W1993019338","https://openalex.org/W2004202690","https://openalex.org/W2070131010","https://openalex.org/W2136291881","https://openalex.org/W1989974449","https://openalex.org/W2171214880","https://openalex.org/W2100164793","https://openalex.org/W2472338587","https://openalex.org/W3087954680","https://openalex.org/W2273247663"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}